US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist
  • 0.3717
  • +0.0437+13.32%
Close Feb 14 16:00 ET
  • 0.3521
  • -0.0196-5.27%
Post 19:36 ET
5.17MMarket Cap-0.01P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Cyclacel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q310.000K / 10.000K--
Aug 14, 20242024/Q24.000K / 15.000K--
May 14, 20242024/Q129.000K / 0.000--
Mar 19, 20242023/Q431.000K / 0.000--
Nov 13, 20232023/Q316.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q310.000K / 10.000K--
Aug 14, 20242024/Q24.000K / 15.000K--
May 14, 20242024/Q129.000K / 0.000--
Mar 19, 20242023/Q431.000K / 0.000--
Nov 13, 20232023/Q316.000K / 0.000--

Unlock Free Earnings Estimates

Cyclacel Pharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.